NDC 0068-0509

Rifamate

Rifampin And Isoniazid

Rifamate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Rifampin; Isoniazid.

Product ID0068-0509_1e0a48bf-ad7b-454b-aea6-82ae1b841302
NDC0068-0509
Product TypeHuman Prescription Drug
Proprietary NameRifamate
Generic NameRifampin And Isoniazid
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date1975-07-11
Marketing CategoryANDA / ANDA
Application NumberANDA061884
Labeler Namesanofi-aventis U.S. LLC
Substance NameRIFAMPIN; ISONIAZID
Active Ingredient Strength300 mg/1; mg/1
Pharm ClassesRifamycin Antibacterial [EPC],Rifamycins [CS],Antimycobacterial [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0068-0509-60

60 CAPSULE in 1 BOTTLE (0068-0509-60)
Marketing Start Date1975-07-11
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0068-0509-60 [00068050960]

Rifamate CAPSULE
Marketing CategoryANDA
Application NumberANDA061884
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1975-07-11

Drug Details

Active Ingredients

IngredientStrength
RIFAMPIN300 mg/1

OpenFDA Data

SPL SET ID:3cc36609-8e2d-4caa-a8e0-c0367e3e52df
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198203
  • 206702
  • UPC Code
  • 0300680509603
  • Pharmacological Class

    • Rifamycin Antibacterial [EPC]
    • Rifamycins [CS]
    • Antimycobacterial [EPC]

    NDC Crossover Matching brand name "Rifamate" or generic name "Rifampin And Isoniazid"

    NDCBrand NameGeneric Name
    0068-0509Rifamaterifampin and isoniazid
    61748-017IsonaRifRifampin and Isoniazid

    Trademark Results [Rifamate]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RIFAMATE
    RIFAMATE
    73038149 1025618 Live/Registered
    DOW CHEMICAL COMPANY, THE
    1974-11-25

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.